Immune checkpoint inhibitor‐related molecular markers predict prognosis in extrahepatic cholangiocarcinoma

Abstract Background Therapeutic approaches for extrahepatic cholangiocarcinoma (EHCC) are limited, due to insufficient understanding to biomarkers related to prognosis and drug response. Here, we comprehensively assess the molecular characterization of EHCC with clinical implications. Methods Whole‐...

Full description

Saved in:
Bibliographic Details
Main Authors: Bao Jin, Yuxin Wang, Baoluhe Zhang, Haifeng Xu, Xin Lu, Xinting Sang, Wenze Wang, Yilei Mao, Pengxiao Chen, Shun Wang, Zhirong Qian, Yingyi Wang, Shunda Du
Format: Article
Language:English
Published: Wiley 2023-10-01
Series:Cancer Medicine
Subjects:
Online Access:https://doi.org/10.1002/cam4.6441
Tags: Add Tag
No Tags, Be the first to tag this record!